Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Chihiro Morishima"'
Autor:
Samuel D. Klebanoff, Lauren B. Rodda, Chihiro Morishima, Mark H. Wener, Yevgeniy Yuzefpolskiy, Estelle Bettelli, Jane H. Buckner, Cate Speake, Marion Pepper, Daniel J. Campbell
Publikováno v:
JCI Insight, Vol 8, Iss 15 (2023)
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that causes debilitating swelling and destruction of the joints. People with RA are treated with drugs that actively suppress one or more parts of their immune system, and these
Externí odkaz:
https://doaj.org/article/13459b7a9d15424893fed20f19913b0c
Autor:
Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim Boonyaratanakornkit, Anna Wald, Stacy Selke, Mark H. Wener, Chihiro Morishima, Alexander L. Greninger, Michael Gale Jr., Tien-Ying Hsiang, Lichen Jing, Michael R. Holbrook, Ian M. Kaplan, H. Jabran Zahid, Damon H. May, Jonathan M. Carlson, Lance Baldo, Thomas Manley, Harlan S. Robins, David M. Koelle
Publikováno v:
JCI Insight, Vol 7, Iss 10 (2022)
BACKGROUND Measuring the immune response to SARS-CoV-2 enables assessment of past infection and protective immunity. SARS-CoV-2 infection induces humoral and T cell responses, but these responses vary with disease severity and individual characterist
Externí odkaz:
https://doaj.org/article/c720e1a7f2ea4a9bb6e8db6d06e7b8ab
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 10, Pp 2501-2503 (2020)
Many serologic tests are now available for measuring severe acute respiratory syndrome coronavirus 2 antibodies to evaluate potential protective immunity and for seroprevalence studies. We describe an approach to standardizing positivity thresholds a
Externí odkaz:
https://doaj.org/article/335fabdb01964b5fb8e695a336133b70
Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing.
Autor:
Tess Hendelman, Anu Chaudhary, Angela C LeClair, Kimberly van Leuven, Jacqueline Chee, Susan L Fink, Emily J Welch, Erwin Berthier, Brook A Quist, Anna Wald, Mark H Wener, Andrew N Hoofnagle, Chihiro Morishima
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0255841 (2021)
BackgroundEfforts to minimize COVID-19 exposure during the current SARS-CoV-2 pandemic have led to limitations in access to medical care and testing. The Tasso-SST kit includes all of the components necessary for remote, capillary blood self-collecti
Externí odkaz:
https://doaj.org/article/e2425dcf493c44129f94341902a0ea55
Autor:
Gregory N Dietsch, Hailing Lu, Yi Yang, Chihiro Morishima, Laura Q Chow, Mary L Disis, Robert M Hershberg
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148764 (2016)
UNLABELLED:VTX-2337 (USAN: motolimod) is a selective toll-like receptor 8 (TLR8) agonist, which is in clinical development as an immunotherapy for multiple oncology indications, including squamous cell carcinoma of the head and neck (SCCHN). Activati
Externí odkaz:
https://doaj.org/article/76249c953a2e4007813d22b488c7aa4a
Autor:
Jessica Wagoner, Chihiro Morishima, Tyler N Graf, Nicholas H Oberlies, Elodie Teissier, Eve-Isabelle Pécheur, John E Tavis, Stephen J Polyak
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e16464 (2011)
Silymarin prevents liver disease in many experimental rodent models, and is the most popular botanical medicine consumed by patients with hepatitis C. Silibinin is a major component of silymarin, consisting of the flavonolignans silybin A and silybin
Externí odkaz:
https://doaj.org/article/f390f16eea87423aa5bd1b0c0ddc1c4b
Autor:
Davide Bedognetti, Patrick Danaher, Mary L. Disis, Brent A. Hanks, Chihiro Morishima, Nina Bhardwaj, Anna C. Pavlick, Andres M. Salazar, Jason J. Luke, Ena Wang, Sarah Warren, Philip Friedlander, Lisa Lundgren, Steven P. Fling, Marc S. Ernstoff, Ana Belen Blazquez, Tibor Keler, Brendan D. Curti, Martin A. Cheever, Sreekumar Balan, Leonard A D'Amico, Michael J. Yellin, Thomas A. Davis, Bruce W. Hess, Bob Salim, Laura Vitale, Joseph M. Beechem, Elad Sharon, Darawan Rinchai, Nirasha Ramchurren, Brian R. Gastman, Andrea Crocker, Thomas Hawthorne, Mark R. Albertini
Publikováno v:
Nature Cancer. 1:1204-1217
Generating responses to tumor antigens poses a challenge for immunotherapy. This phase II trial (NCT02129075) tested fms-like tyrosine kinase 3 (Flt3) ligand pre-treatment enhancement of responses to dendritic cell (DC)-targeting vaccines. We evaluat
Autor:
Paul Nghiem, Chihiro Morishima, Janis M. Taube, Evan Greene, Greg Finak, Raphael Gottardo, Steven P. Fling, Candice D. Church, Leonard A D'Amico, Nina Bhardwaj, Nirasha Ramchurren, Martin A. Cheever
Publikováno v:
Patterns, vol. 2, no. 12, pp. 100372
Patterns
Patterns
Summary We introduce a new method for single-cell cytometry studies, FAUST, which performs unbiased cell population discovery and annotation. FAUST processes experimental data on a per-sample basis and returns biologically interpretable cell phenotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92dc0b6873819de8f66c57374d3c3ef8
https://serval.unil.ch/resource/serval:BIB_4AF9E6EB0D95.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_4AF9E6EB0D95.P001/REF.pdf
Autor:
Andreanne M. Lacroix, Steven P. Fling, Lawrence Fong, Chihiro Morishima, Frederick Millard, Nirasha Ramchurren, Russell K. Pachynski, Martin A. Cheever, Anne Gregoire, Lauren C. Harshman, Paul Monk, Omer Kucuk, Leonard A D'Amico, Leonard Joseph Appleman, Michel Morre, John D. Seigne, Caroline Duault, Judith C Kaiser, Russell Z. Szmulewitz, Evan Y. Yu, Bruce W. Hess, Rhonda L. Bitting, Holden T. Maecker
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Journal for immunotherapy of cancer, vol 9, iss 8
Journal for Immunotherapy of Cancer
Journal for immunotherapy of cancer, vol 9, iss 8
Journal for Immunotherapy of Cancer
BackgroundSipuleucel-T (sip-T) is a Food and Drug Administration (FDA)-approved autologous cellular immunotherapy for metastatic castration-resistant prostate cancer (mCRPC). We hypothesized that combining sip-T with interleukin (IL)-7, a homeostatic
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 10, Pp 2501-2503 (2020)
Emerging Infectious Diseases
Emerging Infectious Diseases
Many serologic tests are now available for measuring severe acute respiratory syndrome coronavirus 2 antibodies to evaluate potential protective immunity and for seroprevalence studies. We describe an approach to standardizing positivity thresholds a